Suche nachTanya Leonard

Region
Status
Waren und Dienstleistungen
Land
Aktenzeichen
Marke
Klasse(n)
Inhaber
Anmeldung
Eintragung
Schutzende
Status
USPTO
85227651
ORENCIA DIRECTJECT
5
Bristol-Myers Squibb Company
27.01.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85124057
BYONMET
5
Bristol-Myers Squibb Company
07.09.2010
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85041151
REALM
42
Bristol-Myers Squibb Company
18.05.2010
-
-
ABANDONED - EXPRESS
USPTO
77944902
GREXLO
5
Bristol-Myers Squibb Company
25.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77944885
ONGLIPA
5
Bristol-Myers Squibb Company
25.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77944882
ONGLIP
5
Bristol-Myers Squibb Company
25.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77942410
16354445
Bristol-Myers Squibb Company
23.02.2010
-
-
ABANDONED - EXPRESS
USPTO
77941178
QUVIDRA
5
Bristol-Myers Squibb Company
22.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77941172
DURSPONSE
5
Bristol-Myers Squibb Company
22.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77938683
PLORADRO
5
Bristol-Myers Squibb Company
18.02.2010
-
-
ABANDONED - NO STATEMENT OF USE FILED

Darum lohnt sich ein kostenfreier TMDB Account

Marken überwachen und schützen

Wenn Sie eine Markenüberwachung eingerichtet haben, erhalten Sie automatisch eine E-Mail über Nachahmer und Trittbrettfahrer. So funktioniert unkomplizierter Markenschutz in Echtzeit.

Marken ganz einfach folgen

Wenn Sie einer Marke folgen, erhalten Sie eine E-Mail bei neuen Anmeldungen, Widersprüchen, Fristen und Verlängerungen u.v.m. – So bleiben Sie auf dem Laufenden was die Entwicklung einer Marke angeht.

Kostenfrei registrieren
USPTO
77938662
IMSYSREV
5
Bristol-Myers Squibb Company
18.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77938644
FAREVLA
5
Bristol-Myers Squibb Company
18.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77933562
ABLYMET
5
Bristol-Myers Squibb Company
11.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77927016
VIGMECT
5
Bristol-Myers Squibb Company
03.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77927002
ESIGNEO
5
Bristol-Myers Squibb Company
03.02.2010
-
-
ABANDONED - AFTER PUBLICATION
USPTO
77926990
ABMETEB
5
Bristol-Myers Squibb Company
03.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77926986
ABBMETA
5
Bristol-Myers Squibb Company
03.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77926976
KEZAGIA
5
Bristol-Myers Squibb Company
03.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77926972
YUVETIQ
5
Bristol-Myers Squibb Company
03.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
77926971
YUVETIC
5
Bristol-Myers Squibb Company
03.02.2010
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78941603
ADNEXUS THERAPEUTICS
42
ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
31.07.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78941598
ADNEXUS THERAPEUTICS
5
ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
31.07.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78940914
BELOW
42
Bristol-Myers Squibb Company
31.07.2006
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78936658
REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION
42
Bristol-Myers Squibb Company
25.07.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78918742
DELBAVA
5
Bristol-Myers Squibb Company
28.06.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78893815
LIVSURVA
5
Bristol-Myers Squibb Company
26.05.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78887712
APPRAISE
42
Bristol-Myers Squibb Company
19.05.2006
-
-
ABANDONED - EXPRESS
USPTO
78887709
APPEAR
42
Bristol-Myers Squibb Company
19.05.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78887705
ASSIGN
42
Bristol-Myers Squibb Company
19.05.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78869777
BARACLUDE
1641
Bristol-Myers Squibb Company
26.04.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78869008
BREGLIV
5
Bristol-Myers Squibb Company
25.04.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78868985
FIMITAR
5
Bristol-Myers Squibb Company
25.04.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78857442
ALSAXLO
5
Bristol-Myers Squibb Company
10.04.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78856541
SPRING SUPPORT, PATIENT RESOURCES, INFORMATION AND GUIDANCE
1641
Bristol-Myers Squibb Company
07.04.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78856530
CACELGO
5
Bristol-Myers Squibb Company
07.04.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78839663
NEUROSCIENCE THERAPEUTIC EXCELLENCE
51641
Bristol-Myers Squibb Company
17.03.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78834311
KOSAN BIOSCIENCES
5
KOSAN BIOSCIENCES INCORPORATED
10.03.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78833318
X RESEARCH AN EDUCATIONAL JOURNEY
2841
Bristol-Myers Squibb Company
09.03.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78830846
ONCOLOGY LEADERSHIP FOR THE 21ST CENTURY
51642
Bristol-Myers Squibb Company
07.03.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78805385
ONCOLOGY INNOVATION INTERCHANGE
3542
Bristol-Myers Squibb Company
02.02.2006
-
-
ABANDONED - NO STATEMENT OF USE FILED

Suchergebnisse 1 - 41 von 437

Wir lieben Marken.
Und betreuen Sie gerne.

Sie erreichen uns von Montag bis Freitag zwischen 08:00–16:00 Uhr.

Kontaktieren Sie uns.

Wir verwenden Cookies, um Ihre Einstellungen und Statistiken zu speichern und unseren Inhalt zu verbessern. Durch Klicken auf "Alle akzeptieren" akzeptieren Sie die Verwendung von Cookies.

Akzeptieren